PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
21-Feb-2022 CD Formulation Offers Customized Synthesis to Meet the Demand for Lipid Excipients CD Formulation
16-Feb-2022 PerkinElmer’s SIRION Biotech Teams with Centre for Genomic Regulation to Develop New Generation AAV Vectors for Type 1 and Type 2 Diabetes Gene Therapy PerkinElmer
16-Feb-2022 Pfizer and OPKO’s Once-Weekly NGENLA™ (somatrogon) Injection Receives Marketing Authorization in European Union for Treatment of Pediatric Growth Hormone Deficiency Pfizer
16-Feb-2022 MODERNA ANNOUNCES PLAN TO EXPAND FOOTPRINT IN ASIA WITH FOUR ADDITIONAL SUBSIDIARIES MODERNA
11-Feb-2022 CD Formulation: A Leading Manufacturer of Excipients for Pharmaceutical Preparation CD Formulation
10-Feb-2022 Tiziana Life Sciences CEO to Present at Annual BIO CEO & Investor Conference Tiziana Life Sciences
10-Feb-2022 Ixaka Expands Management Team with Multiple Appointments Ixaka Ltd
10-Feb-2022 Kite, a Gilead Company, continues to advance research with longest CAR T cell therapy follow-up data at the 4th European CAR T-cell Meeting Kite, a Gilead Company
09-Feb-2022 Book to attend the Parallel Trade conference before seats are filled SMi Group
09-Feb-2022 Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report Novotech
09-Feb-2022 Alfa Chemistry—A Supplier of Active Pharmaceutical Ingredients Alfa Chemistry
08-Feb-2022 Oxurion to Participate in the 2022 BIO CEO and Investor Conference Oxurion
08-Feb-2022 Record year for industrial biotechnology grants and investments Novo Nordisk
08-Feb-2022 Amolyt Pharma Selected for the French Tech 120 Program Amolyt Pharma
08-Feb-2022 DuPont invests in bioprocessing supply chain to enhance purchasing of its products for drug development DuPont
08-Feb-2022 Sales of MRI Compatible Patient Monitoring Systems Set to Soar in Asia-Pacific in Future P&S Intelligence
07-Feb-2022 DFE Pharma appoints Martti Hedman as new CEO DFE Pharma
07-Feb-2022 Biomunex and Institut Curie pursue strategic collaboration for development of disruptive non-conventional T cell redirection approach to treating cancer Andrew Lloyd Associates
03-Feb-2022 Parkinson’s UK and Domainex collaborate to develop therapies targeting neuroinflammation to slow the progression of Parkinson’s Domainex Ltd
03-Feb-2022 ORTHOPAEDIC SPECIALISTS JOIN FORCES TO WIDEN ACCESS TO NOVEL KNEE OSTEOARTHRITIS TREATMENT FOR PATIENTS ACROSS EUROPE Arthrosamid